These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20222469)

  • 41. Cleavage by RNase P of gene N mRNA reduces bacteriophage lambda burst size.
    Li Y; Altman S
    Nucleic Acids Res; 1996 Mar; 24(5):835-42. PubMed ID: 8600449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Developing RNase P ribozymes for gene-targeting and antiviral therapy.
    Trang P; Kim K; Liu F
    Cell Microbiol; 2004 Jun; 6(6):499-508. PubMed ID: 15104592
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro construction of effective M1GS ribozymes targeting HCMV UL54 RNA segments.
    Su YZ; Li HJ; Li YQ; Chen HJ; Tang DS; Zhang X; Jiang H; Zhou TH
    Acta Biochim Biophys Sin (Shanghai); 2005 Mar; 37(3):210-4. PubMed ID: 15756425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design of short external guide sequences (EGSs) for cleavage of target molecules with RNase P.
    Werner M; Rosa E; George ST
    Nucleic Acids Symp Ser; 1997; (36):19-21. PubMed ID: 9478194
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of External Guide Sequences' (EGS) Efficiency as Inducers of RNase P-Mediated Cleavage of mRNA Target Molecules.
    Jani S; Jackson A; Davies-Sala C; Chiem K; Soler-Bistué A; Zorreguieta A; Tolmasky ME
    Methods Mol Biol; 2018; 1737():89-98. PubMed ID: 29484589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Engineered RNase P Ribozymes Effectively Inhibit the Infection of Murine Cytomegalovirus in Animals.
    Li W; Liu Y; Wang Y; Li R; Trang P; Tang W; Yang Z; Wang Y; Sun X; Xing X; Lu S; Liu F
    Theranostics; 2018; 8(20):5634-5644. PubMed ID: 30555569
    [No Abstract]   [Full Text] [Related]  

  • 47. Human cytomegalovirus UL49 encodes an early, virion-associated protein essential for virus growth in human foreskin fibroblasts.
    Zhu F; Yuan J; Li HJ; Zeng ZF; Luo ZW; Li SQ; He CQ; Jia XF; Zhang X; Zuo H; Liu YM; Chang M; Li YQ; Zhou TH
    Arch Virol; 2016 May; 161(5):1273-84. PubMed ID: 26898402
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of aac(6')-Ib-mediated amikacin resistance by nuclease-resistant external guide sequences in bacteria.
    Soler Bistué AJ; Martín FA; Vozza N; Ha H; Joaquín JC; Zorreguieta A; Tolmasky ME
    Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13230-5. PubMed ID: 19666539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of human cytomegalovirus UL36 and UL37 genes is required for viral DNA replication.
    Smith JA; Pari GS
    J Virol; 1995 Mar; 69(3):1925-31. PubMed ID: 7853536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of gene expression by RNase P.
    Lundblad EW; Altman S
    N Biotechnol; 2010 Jul; 27(3):212-21. PubMed ID: 20211282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli.
    Trang P; Lee M; Nepomuceno E; Kim J; Zhu H; Liu F
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5812-7. PubMed ID: 10811889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Engineered RNase P ribozymes increase their cleavage activities and efficacies in inhibiting viral gene expression in cells by enhancing the rate of cleavage and binding of the target mRNA.
    Zou H; Lee J; Kilani AF; Kim K; Trang P; Kim J; Liu F
    J Biol Chem; 2004 Jul; 279(31):32063-70. PubMed ID: 15169770
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of bacterial RNase P RNA as a drug target.
    Willkomm DK; Gruegelsiepe H; Goudinakis O; Kretschmer-Kazemi Far R; Bald R; Erdmann VA; Hartmann RK
    Chembiochem; 2003 Oct; 4(10):1041-8. PubMed ID: 14523922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Salmonella-mediated delivery of RNase P-based ribozymes for inhibition of viral gene expression and replication in human cells.
    Bai Y; Li H; Vu GP; Gong H; Umamoto S; Zhou T; Lu S; Liu F
    Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7269-74. PubMed ID: 20360564
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcription analysis and sequence of the putative murine cytomegalovirus DNA polymerase gene.
    Elliott R; Clark C; Jaquish D; Spector DH
    Virology; 1991 Nov; 185(1):169-86. PubMed ID: 1718083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effective inhibition of human immunodeficiency virus 1 replication by engineered RNase P ribozyme.
    Zeng W; Chen YC; Bai Y; Trang P; Vu GP; Lu S; Wu J; Liu F
    PLoS One; 2012; 7(12):e51855. PubMed ID: 23300569
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gene cloning of the human cytomegalovirus (HCMV) antigen reactive with the serum from a HCMV-infected patient.
    Kim MN; Park CG; Hwang ES; Lim DG; Park JW; Seoh JY; Kook YH; Lee HJ; Choi SB; Cha CY
    J Korean Med Sci; 1994 Dec; 9(6):476-81. PubMed ID: 7786444
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inactivation of expression of two genes in Saccharomyces cerevisiae with the external guide sequence methodology.
    Cheng X; Ko JH; Altman S
    RNA; 2011 Mar; 17(3):544-9. PubMed ID: 21233222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dissecting human cytomegalovirus gene function and capsid maturation by ribozyme targeting and electron cryomicroscopy.
    Yu X; Trang P; Shah S; Atanasov I; Kim YH; Bai Y; Zhou ZH; Liu F
    Proc Natl Acad Sci U S A; 2005 May; 102(20):7103-8. PubMed ID: 15883374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human cytomegalovirus microRNA miR-US25-1-5p inhibits viral replication by targeting multiple cellular genes during infection.
    Jiang S; Qi Y; He R; Huang Y; Liu Z; Ma Y; Guo X; Shao Y; Sun Z; Ruan Q
    Gene; 2015 Oct; 570(1):108-14. PubMed ID: 26055091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.